Osteoporosis: Prevention with estrogens in women over 60

Maturitas

Volumn 33, Issue 1, 1999, Pages 1-6

  Palacios, Santiago ^a  

^a Instituto Palacios de Salud Y Medicina de la Mujer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN;

AGING; BONE ATROPHY; BONE MASS; BONE MINERAL; ESTROGEN THERAPY; FALLING; HIP FRACTURE; HUMAN; OSTEOPOROSIS; REVIEW; RISK FACTOR;

EID: 0033600765     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00029-8     Document Type: Note

References (54)

1. Prior JC, Vigna JM, Schechter MT, Burgess AG. Spinal bone loss and ovulatory disturbances. N Engl Med 1990;323:1221-7.
2. Palacios S, Menéndez C, Jurado AR, Vargas JC. Effects of percutaneous oestradiol versus oral oestrogens on bone density. Maturitas 1995;20:209-13.
3. Davis JW, Ross PD, Waswich RD, MacLean CJ, Vogel JM. The long-term precision of bone loss rate measurements among postmenopausal. Int Med 1991;117:1-9.
4. Melton JL-III. How many women have osteoporosis now? J Bone Miner Res 1995;10:175-7.
5. Ross P. Osteoporosis: Frequency consequences and risk factors. Arch Intern Med 1996;156:1399-411.
6. Grady D, Rubin S, Petitti D, Fox C, Black D, Ettinger B, Ernster V, Cummings S. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 1992;117(12):1016-37.
7. Resnik N, Greenspan S. "Senile" osteoporosis reconsidered. JAMA 1989;261:1025-9.
8. Greendale G, Barret-Connor E, Ingles S, Haile R. Late physical and functional effects of osteoporotic fracture in women: The Rancho Bernardo study. J Am Geriatr Soc 1995;43:955-61.
9. Barzel US. Estrogens in the prevention and treatment of postmenopausal osteoporosis: A review. Am J Med 1988;85:847-50.
10. Lindsay R. Why do estrogens prevent bone loss? Bailleres Cli Obst Gynaecol 1991;5:837-52.
11. Heaney R. Osteoporosis made easy. J Am Geriatr Soc 1990;38:1159-60.
12. Richelson L, Wahner H, Melton L, Riggs B. Relative contributions of ageing and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1994;311:1278-85.
13. Hansen MA, Overgaard K, Christiansen C. Spontaneous postmenopause bone loss in different skeletal areas: Followed up for 15 years. J Bone Miner Res 1995;10:205-10.
14. Palacios S, Menéndez C, Jurado AR. Prevention and treatment of postmenopausal osteoporosis. In: Palacios S, editor. Menopause Present and Future. Madrid:MIRPAL, 1994: 27-35.
15. Karen M. HRT in elderly women. Clin Obstet Gynaecol 1996;39:912-32.
16. Greenspan SL, Maitland LA, Myers ER, Krasnow MB, Kido TK. Femoral bone loss progresses with age: A longitudinal study in women aged 65. J Bone Miner Res 1994;9(12):1959-65.
17. Hannan MT, Felson DT, Anderson JJ. Bone mineral density in the elderly men and women: Result from the Framingham osteoporosis study. J Bone Miner Res 1992;7(5):547-53.
18. Christiansen C, Riis BJ. 17β-Estradiol and continuous norethisterone: A unique treatment for establish osteoporosis in elderly women. J Clin Endocrinol Metabol 1990;71:836-41.
19. Tremollieres F, Puilles JM, Louvet JP, Ribot C. Preventive effects on postmenopausal bone loss of percutaneous 17β-estradiol in early and late menopause. In: Osteoporosis. Proceeding of the Third International Symposium on Osteoporosis,1990: 1910-1915.
20. Lindsay R, Hart D, Aitken J, MacDonald EB, Anderson JB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976;1:1038-41.
21. Aitken J, Hart D, Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. BMJ 1973;3:515-8.
22. Holland E, Leather A, Studd J. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Br J Obstet Gynaecol 1995;102:238-42.
23. Grey A, Cundy T, Reid Y. Continuos combined oestogen/progestin therapy is well tolerated and increases bone density at the hip and spine in postmenopausal osteoporosis. Clin Endocrinol 1994;40:671-7.
24. Ettinger B, Genant H, Cann C. Long-term estrogen therapy prevents bone loss and fracture. Ann Intern Med 1985;102:319-24.
25. Cumming S, Kelsey J, Nevitt M, O'Dowd K. Epidemiology of osteoporosis and osteoporotic fracture. Epidemiol Rev 1985;7:178-208.
26. Hutchinson T, Polansky S, Feisten A. Postmenopausal oestrogens protect against fractures of hip and distal radius a case-control study. Lancet 1979;2:705-9.
27. Lindsay R, Hart D, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980;2:1151-4.
28. Weiss N, Ure C, Ballard J, Williams A, Daling J. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195-8.
29. Kreiger N, Kelsey J, Holdford T, O'Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 1982;116:141-8.
30. Cauley J, Seeley D, Ensrud K, Ettinger B, Black D, Cummings SR. Study of osteoporotic fractures research group: Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9-16.
31. Lufkin E, Wahner H, O'Fallon W, Hodgson SF, Kotowicz MA, Land AW, Judd HL, Caplan RH, Riggs BL. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1981;95:28-31.
32. Kanis J, Johnell O, Gulberg B, Allander E, Dilsen G, Gennari C, Lopes Vaz AA, Lyritis GR, Mazzuoli G, Miravet L, et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fractures. BMJ 1992;305:1124-8.
33. Paganini-Hill A, Ross R, Gerkins V, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981;95:28-31.
34. Lufkin EG, Hodgson SF, Kotowicz MA, O' Fallon WM, Wahner HW, Riggs BL. The use of transdermal estrogen treatment in osteoporosis. In: Christiansen C, Overgard K, editors. Osteoporosis 1990. Proceeding of the Third International Symposium on Osteoporosis. Osteopress 3: 199.
35. Naessen T, Person Y, Adami H, Bergström R, Berkgvist L. Hormone replacement therapy and the risk for the first hip fracture. Ann Intern Med 1990;113:95-103.
36. Horsman A, Jones M, Franris R, Nordin BBC. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 1983;309:1405-7.
37. Lindsay R, Hart CM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynaecol 1983;63:759-63.
38. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Int Med 1987;104:40-4.
39. Ribbot C, Tremollieres F, Oilles JM. Cyclic estraderm TTS so plus oral progestogen in the prevention of postmenopausal bone loss over 24 months. In: Osteoporosis 1990. Proceeding of the Third International Symposium. pp. 1979-1984.
40. Lindsay R, Hart DM, MacLean A, Clark AC, Kraszewski A, Garwood J. Bone response to termination of oestrogen treatment. Lancet 1987;1:1325-7.
41. Christiansen C, Christiansen M, Transbol Y. Bone mass in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy. Lancet 1981;1:459-61.
42. Christiansen C, Riis B, Nilas L, Rodbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet 1985;2:800-1.
43. Erdtsieck RJ, Pols HA, van Kuijk C, Birkenhager-Frenkel DH, Zeelenberg J, Kooy PP, Mulder P, Birkenhager JC. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone of decanoate. J Bone Miner Res 1994;9:277-88.
44. Felson D, Zhang Y, Hannan M, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-6.
45. Kiel DP, Felson DTY, Anderson JJ, Wilson PNF, Moskowirz MA. Hip fracture and the use of estrogens in postmenopausal women; The Framingham study. N Engl J Med 1987;317:1169-74.
46. Marx C, Dailey G, Cheney C, Vint V, Muchmore D. Do estrogens improve bone mineral density in osteoporotic women over age of 65? J Bone Miner Res 1992;7: 1275-9.
47. Nachtigall L, Nachtigall RH, Nachtigall RD, Beckman E. Estrogen replacement therapy I: A 10-years prospective study in the relationship to osteoporosis. Obstet Gynecol 1997;53:277-81.
48. Quigley M, Martin P, Burnier A, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1979;156:1516-23.
49. Heaney R. Estrogen-calcium interactions in the postmenopause: A quantitative description. Bone Mineral 1990;11:67-84.
50. Ettinger B, Grady D. Maximising the benefit of estrogen therapy for prevention of osteoporosis. Menopause 1994;1:19-24.
51. Schneider D, Barret-Connor E, Morton D. Timing of postmenopausal estrogen for optimal bone mineral density: The Rancho Bernardo study. JAMA 1997;277:543-7.
52. Melton L, Wahner H, Richelson L, O'Fallon W, Riggs B. Osteoporosis and the risk of hip fracture. Am J Epidemiol 1996;124:246-61.
53. Gärdsell S, Johnell O, Nilsson B. Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int 1989;298:1486-8.
54. Winner S, Morgan C, Evan J. Perimenopausal risk of falling and incidence of distal forearm fracture. Br Med J 1989;289:1486-8.